Business modelsB2B

Products 81 to 90 of 162

Hornless cattle by Recombinetics
Biotech components: Animal + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/01/21 15:00 (4 years ago)
Date last modified: 2020/01/21 15:00 (4 years ago)
Known funding amount: 34,000,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Animal
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Hydrogen Sulfide Sourced Fuels by Ginkgo Bioworks
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 11:54 (5 years ago)
Known funding amount: 6,438,793 USD
Funding types: Government
Industry: Energy
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Improved Rubisco by ARC Center of Excellence for Translational Photosynthesis at the Australian National University
Biotech components: Bacteria
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (3 years ago)
Date last modified: 2020/12/18 14:38 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): University
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
INXN-3004: AML by Intrexon
Biotech components: Virus
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (4 years ago)
Date last modified: 2020/02/10 09:59 (4 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Isobutanol by Gevo
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 92,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: GEVO (NASDAQ)
Value chain stage: Input
Isobutene by Global Bioenergies
Biotech components: Plant
Business models: B2B
Country of production: France
Country of distribution: France + Netherlands + Germany
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 23,000,000 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: ALGBE (EPA)
Value chain stage: Input
L-Methionine by Metabolic Explorer SA
Biotech components: Enzyme
Business models: B2B
Country of production: France
Country of distribution: France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Feed
Production process: Closed Production
Source: SynBio Database
Trading symbol: METEX (EPA)
Value chain stage: Input
Biotech components: Enzyme
Business models: B2B
Country of production: Denmark
Country of distribution: Denmark + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:50 (5 years ago)
Known funding amount: 12,880,000 DKK
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: Web search
Trading symbol: NZYM-B (CPH)
Value chain stage: Input
Luminase PB-100 by BASF
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: Germany + USA + Brazil + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 85,090,000 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BASF SE (ETR)
Value chain stage: Input
Malonic Acid by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 13,100,000 USD
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input